Precision Vaccinations (PVax) is an international publisher of research-based information people can trust to make informed vaccination decisions.
Our goal is to empower main-street conversations between healthcare providers and patients to reduce the under-use, over-use, and misuse of vaccines.
PVax's innovative publishing model ... the 'Enhanced Wiki for Vaccines ... integrates research-based, fact-checked information into its consumer-friendly vaccine library.
As digital media embraces AI-content creation and search engines, curtail disclosures, 'we believe vaccine information should be curated and verified by trusted healthcare providers for clinical accuracy'... and vaccine information publishers must earn their readers' trust ....each day!
Recent data indicates "ChatGPT drives misinformation in healthcare," which is an indication of inaccuracies and un-scientific bias arising when AI creates vaccine content is not fact-checked by healthcare providers.
Publish trustworthy information empowering people to live life to the fullest!
Did You Know
In 2023, Americans' confidence and trust in the media has fallen to record lows.
However, in 2022, the most trusted healthcare provider on main-street, pharmacists, delivered more vaccines than doctors.
- 93% of patients read online news
- 82% of adults surveyed said they seek out trustworthy news
- 39% of people trust information from providers
- 37% of seniors now get vaccinations from pharmacies
- 22% of press releases exaggerate causal claims from correlational findings in observational studies.
PVax Vaccine Library
PVax's vaccine library integrates peer-reviewed information from the European Medicines Agency, the World Health Organization, the UK, India, China, Brazil, Australia, and other agencies. Furthermore, PVax increases clinical trial transparency by integrating study results. And we curate our content to enhance consumer understanding by targeting the 10th-grade reading language.
Recently, the World Health Organization said, 'vaccine misinformation is a significant threat to global health that could reverse decades of progress in tackling preventable diseases.
Our news team has been fact-checking health news for over 20 years and commits to publishing accurate information. We stand by the information we publish; if it's incorrect, we will change it as quickly as possible. In addition, we take many steps to ensure accuracy, such as:
- We investigate claims with skepticism, question assumptions, challenge conventional wisdom;
- We confirm information with subject-matter experts and seek to corroborate what sources tell us by talking with other informed people or consulting documents;
- We verify content, such as technical terms, stats, etc., against source documents or clarify who provides the information. For example, we may share relevant components of a story with a primary source or an outside expert to verify them.
In December 2021, PVax launched an innovative patient-centric vaccine Rate feature, empowering consumers to rate their favorite vaccines. In addition, PVax's proprietary data helps guide content editing and syndication strategies. And complies with FactCheck.org principles.
- Trusted - only licensed providers edit our content, delivering 100% transparency
- Understandable - our clinical information is written with a positive voice, translated into "main street" conversation
- Breaking research is contextually integrated into the news as it is published;
- Experience - each article is designed with uniform navigation, offering a consistent learning experience
Vaccine Market Overview
Life-saving vaccines have had a profound impact on the world. Globally, millions of fewer deaths occur because vaccines protect people from disease. Today, almost anyone can be immunized against deadly diseases.
According to the CDC, almost 3.5 billion vaccine doses have been distributed in the United States over the past ten years. And research says that for every $1 spent on vaccines, $3 indirect benefits are realized from an economic perspective. New research projects the overall vaccine market will reach about $149 billion by 2026.
And since the Human Genome Project's success in 2000, people have been gaining awareness of their genetic makeup and ways to enhance their quality of life. Soon, the promise of personalized vaccines will become a reality, disrupting the one-size-fits-all vaccination model.
PV publishes breaking news posts, featured news articles, disease information channels, and an extensive vaccine library. These pages are reviewed for relevance and accuracy daily.
PV supports these industry-leading non-profit health publishing criteria:
Inclusiveness is at the heart of thinking and acting as journalists. The complex issues we face as a society require respect for different viewpoints. Race, class, generation, gender, and geography affect perspective. Reflecting these differences in our reporting leads to better, more nuanced stories and a better-informed community. Therefore, we seek diverse voices in our management and reporting staff.
Precision Vax publishes vaccine information based on valid research from universities, government agencies, pharmaceutical manufacturers, and the WHO. Furthermore, these organizations' editorial biases do not influence PV's independently published content. PV cites potential conflicts of interest on the same page as the published, relevant work.
PV's digital newsroom is insulated from any interaction with advertisers. We do not accept gifts or remuneration to avoid any conflicts. And our news-gathering team is independent of commercial or political interests. Additionally, we do not allow third-parties to "ghost-write" news articles.
If you have any questions, contact [email protected].
Medical Advisory Team
The Medical Advisory Team works closely with pharmacists, doctors, and nurses across various specialty areas to ensure PrecisionVax's published content is accurate, actionable, and understandable. If you have any questions, please contact Dr. Robert Carlson at [email protected].
Various PVax policies are listed on this webpage.
Superior Content Management System
PVax's proprietary content management system empowers the 3rd generation of multi-brand, producer-controlled syndication networks, delivering superior mobile-user experiences. In addition, the CHAD 3.2 digital environment maximizes AI utility throughout PVax's fact-checked information network.
PVax Digital Network
PVax's digital network includes PrecisionVaccinations.com, Vax-Before-Travel.com, and various syndication affiliates.
Precision Vax, LLC is a 100% woman-owned private enterprise founded in 2016. Karen McClorey Hackett, Precision Vax's president, is committed to transparency in our ownership structure and revenue sources. Karen launched her career with IBM and has invested in digital health enterprises since 1997. Here is Karen's Linkedin profile.
Vax Before Travel™ and InstantRx™ are trademarks owned by Precision Vax LLC.
We primarily produce our revenues from advertising. As such, our editorial team has no relationship or communications with any advertiser.
Our dominant digital advertiser is Google Adsense. Please note that advertising networks such as Adsense integrates user-tracking capabilities that may not be obvious to users. Google Ads Terms & Conditions are published at this link. PVax also integrates lead-generation business agreements for clinical trials, diagnostic tests, and vaccine appointments.
Note: PVax was a customer of GoodRx Inc. until 2019. On Feb. 1, 2023 - FTC Enforcement Action to Bar GoodRx from Sharing Consumers’ Sensitive Health Info for Advertising. Under the proposed FTC order, GoodRx will pay a $1.5 million civil penalty for failing to report its unauthorized disclosure of consumer health data to Facebook, Google, and other companies. GoodRx Inc. published a response.
Comments and Concerns
We believe that public feedback is not a one-way street. Instead, we are committed to engaging with you and acting based on your suggestions and other feedback. We are committed to providing greater transparency about how news is produced and offering regular contact and interaction points. In addition, we believe that news organizations are responsible for engaging with the public on the values and issues daily.
We will respond to your request within two business days. Would you mind sending an email to [email protected]?
Karen Hackett, Founder & President